Microglial phagocytosis and regulatory mechanisms after stroke.
Weijie ChenYueman ZhangXiaozhu ZhaiLv XieYunlu GuoChen ChenYan LiFajun WangZiyu ZhuLi ZhengJieqing WanPei-Ying LiPublished in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2022)
Stroke, including ischemic stroke and hemorrhagic stroke can cause massive neuronal death and disruption of brain structure, which is followed by secondary inflammatory injury initiated by pro-inflammatory molecules and cellular debris. Phagocytic clearance of cellular debris by microglia, the brain's scavenger cells, is pivotal for neuroinflammation resolution and neurorestoration. However, microglia can also exacerbate neuronal loss by phagocytosing stressed-but-viable neurons in the penumbra, thereby expanding the injury area and hindering neurofunctional recovery. Microglia constantly patrol the central nervous system using their processes to scour the cellular environment and start or cease the phagocytosis progress depending on the "eat me" or "don't eat me'' signals on cellular surface. An optimal immune response requires a delicate balance between different phenotypic states to regulate neuro-inflammation and facilitate reconstruction after stroke. Here, we examine the literature and discuss the molecular mechanisms and cellular pathways regulating microglial phagocytosis, their resulting effects in brain injury and neural regeneration, as well as the potential therapeutic targets that might modulate microglial phagocytic activity to improve neurological function after stroke.
Keyphrases
- cerebral ischemia
- brain injury
- inflammatory response
- neuropathic pain
- subarachnoid hemorrhage
- lipopolysaccharide induced
- lps induced
- immune response
- atrial fibrillation
- oxidative stress
- blood brain barrier
- spinal cord
- stem cells
- systematic review
- white matter
- toll like receptor
- induced apoptosis
- traumatic brain injury
- spinal cord injury
- transcription factor
- multiple sclerosis
- cell proliferation
- resting state
- risk assessment
- cerebrospinal fluid
- climate change
- single molecule
- cognitive impairment